Zdrowie i gospodarka · 16/01/2003
FDA Releases Guidance on Stability Testing for New Drug Substances and Products
The FDA has made available a guidance document outlining reduced design approaches for stability testing of new pharmaceuticals, developed under the International Conference on Harmonisation (ICH).
Source: Federal Register — Food and Drug AdministrationOpen original release →